|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/155 | |
| A61K 31/192 | |||
| C07C 279/26 | |||
| C07C 323/62 | |||
| A61K 9/00 | |||
| A61P 1/16 | |||
| A61P 3/06 | |||
| A61P 3/10 | |||
| A61P 3/04 | |||
| A61P 9/00 |
| (11) | Patento numeris | 3518912 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17781051.2 |
| Europos patento paraiškos padavimo data | 2017-09-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-08-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/074703 |
| Data | 2017-09-28 |
| (87) | Numeris | WO 2018/060373 |
| Data | 2018-04-05 |
| (30) | Numeris | Data | Šalis |
| 1659435 | 2016-09-30 | FR |
| (72) |
LARUELLE, Claude, FR
BONNAFOUS, Ludovic, FR
|
| (73) |
Nashpharm,
18 avenue Bellevue, 06270 Villeneuve Loubet,
FR
|
| (54) | SEL DE METFORMINE D`ELAFIBRANOR PRESENTANT UNE ACTIVITE DUALE POUR LE TRAITEMENT DE L`OBESITE ASSOCIEE A LA STEATO-HEPATITE NON ALCOOLIQUE (NASH) ET A L`HYPERTRIGLYCERIDEMIE |
| DUAL-ACTION ELAFIBRANOR METFORMIN SALT FOR TREATING OBESITY ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND HYPERTRIGLYCERIDAEMIA |